Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Übersicht 
Founder of Cerimon Pharmaceuticals, Inc., Paul Jai Sekhri is an American businessperson who has been at the head of 10 different companies and presently is Chairman at Compugen Ltd., Chairman of Pharming Group NV, President, Chief Executive Officer & Director at eGenesis, Inc., Venture Partner at Medicxi Ventures (Jersey) Ltd. and Chairman for Pharming NV. Mr. Sekhri is also Member of Ontario Institute for Cancer Research and Managing Director & Operating Partner at Tarrant Capital IP LLC and on the board of 15 other companies.

In his past career Paul Jai Sekhri held the position of Chairman of moksha8 Pharmaceuticals, Inc., Chairman of Topas Therapeutics GmbH, President & Chief Executive Officer for Cerimon Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Lycera Corp., Chief Strategy Officer & EVP-Business Development at Teva Pharmaceutical Industries Ltd., Venture Partner at MPM Capital Inc, Partner-Healthcare Investments at New Leaf Venture Partners LLC, Member-Patrons Council at The Carnegie Hall Society, Inc., President & Chief Business Officer at ARIAD Pharmaceuticals, Inc., Partner at Sprout Group, Senior Vice President-Integrated Care at Sanofi, Inc., Operating Partner & Head-Biotechnology Operations at TPG Biotech Equity LP, Senior VP, Head-Global Search & Evaluation at Novartis Pharma AG, Senior Vice President-Integrated Care at Sanofi SA and Operating Partner at Highline Therapeutics, Inc.

Mr. Sekhri received an undergraduate degree from the University of Maryland and a graduate degree from the University of Maryland School of Medicine.


Aktuelle Stellungen und Verantwortungsbereiche Paul Jai Sekhri 
NameTitel Seit
Veeva Systems Inc.
(Medizinische Ausrüstung)
Independent Director 2014
Ipsen S.A.
(Pharmazeutika)
Independent Director 2018
Compugen Ltd.
(Biotechnologie)
Chairman 2017
Pharming Group N.V.
(Pharmazeutika)
Chairman 2016
Longboard Pharmaceuticals, Inc.
(Biotechnologie)
Director 2020
BiomX Inc.
(Biotechnologie)
Independent Director 2020
Global Alliance for TB Drug Development Director -
LikeMinds, Inc. (Massachusetts) Director -
The Knights Director 2017
eGenesis, Inc. President, Chief Executive Officer & Director 2019
Petra Pharma Corp. Director -
Young Concert Artists, Inc. Director -
The BioExec Institute, Inc. Director -
Orchestra of St. Luke's Director 2018
The Caramoor Center for Music & the Arts, Inc. Director -
Cancer Research Institute Director -
Pharming NV Chairman -
Metropolitan Opera Association, Inc. Director 2018
Cita NeuroPharmaceuticals, Inc. Director -
Tarrant Capital IP LLC Managing Director & Operating Partner -
Ontario Institute for Cancer Research Member -
Medicxi Ventures (Jersey) Ltd. Venture Partner 2020


Anteile an Paul Jai Sekhri 
NameAktien%Wert
Veeva Systems Inc. (VEEV)
(Medizinische Ausrüstung)
29 4240,021%7 517 244 USD
Pharming Group N.V. (PHARM)
(Pharmazeutika)
193 9850,030%170 965 USD
BiomX Inc. (PHGE)
(Biotechnologie)
12 5000,044%20 000 USD
Longboard Pharmaceuticals, Inc. (LBPH)
(Biotechnologie)
00,0000%0 USD


Paul Jai Sekhri: Persönliches Netzwerk 
Meistgelesene News 
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
10.01.BRUNELLO CUCINELLI : Luxuskonzern Cucinelli verzeichnet 31% Umsatzplus im Jahr 2021
MR
07.01.CHRISTIAN KLEIN : Deutschlands Vorzeige-Tech-Konzern am Scheideweg
DP
07.01.TIM COOK : Apple-Chef Cook erhält für 2020 fast 100 Millionen Dollar
RE
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
10.01.PAUL SCHULER : Jahresumsatz von 9,15 Milliarden Franken erwartet
AW
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
10.01.Estelle Brachlianoff wird nächste CEO von Veolia
MR
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Paul Jai Sekhri : Verbindungen